Latest News for: hyperplasia

Edit

Benign Prostatic Hyperplasia Treatment Market 2026: Segmentation Trends, Industry Size, Growth, Regional Opportunities and Forecast

GetNews 23 Jan 2025
Browse 130 market data Tables and 40 Figures spread through 158 Pages and in-depth TOC on "Benign Prostatic Hyperplasia Treatment Market by Type , End User (Hospitals) - Global Forecast to 2026.
Edit

Neurocrine Biosciences Announces Classic Congenital Adrenal Hyperplasia Supplement Published Today in The Journal of Clinical Endocrinology & Metabolism

PR Newswire 21 Jan 2025
About Congenital Adrenal Hyperplasia Congenital adrenal hyperplasia (CAH) is a rare genetic condition that results in an enzyme deficiency that alters the production of adrenal steroid hormones, ...
Edit

Crinetics Announces Positive Topline Results From Phase 2 Trial of Atumelnant in Congenital Adrenal Hyperplasia (CAH)

Nasdaq Globe Newswire 10 Jan 2025
Substantial, Rapid and Sustained Statistically Significant Reductions of Key Biomarkers Achieved Across Doses, Including up to 80% Mean Reduction of Androstenedione ... .
Edit

Crinetics Announces Positive Topline Results From Phase 2 Trial of Atumelnant in Congenital Adrenal Hyperplasia (CAH) Form 8 K (Crinetics Pharmaceuticals Inc)

Public Technologies 10 Jan 2025
Crinetics Announces Positive Topline Results From Phase 2 Trial of Atumelnant in Congenital Adrenal Hyperplasia (CAH) ... Atumelnant is currently in development for congenital adrenal hyperplasia and ACTH-dependent Cushing's syndrome.
Edit

Congenital Adrenal Hyperplasia Pipeline Analysis 2024: FDA Approvals and Emerging Therapies | Becton, Dickinson and ...

GetNews 09 Jan 2025
“" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Congenital Adrenal Hyperplasia Market ... Congenital Adrenal Hyperplasia Overview.
Edit

Neurocrine Biosciences Announces Publication on Traditional Glucocorticoid Treatment in Classic Congenital Adrenal Hyperplasia in Expert Review of Endocrinology & Metabolism

PR Newswire 08 Jan 2025
The review, Glucocorticoid Therapy in Classic Congenital Adrenal Hyperplasia ... Sudden adrenal insufficiency or adrenal crisis can happen in people with congenital adrenal hyperplasia who are not taking enough glucocorticoid (steroid) medicine.
Edit

Sumitomo Pharma America Announces U.S. FDA Approval of GEMTESA® (vibegron) for Men with Overactive Bladder Symptoms Receiving Pharmacological Therapy for Benign Prostatic Hyperplasia

PR Newswire 23 Dec 2024
About Benign Prostatic Hyperplasia Benign prostatic hyperplasia (BPH) is a condition in men in which the prostate gland is enlarged ... Benign Prostatic Hyperplasia (BPH).https.//emedicine.medscape.com/article/437359-print.
Edit

Neurocrine Biosciences Announces Commercial Availability of CRENESSITY™ (crinecerfont) for Children and Adults With Classic Congenital Adrenal Hyperplasia

PR Newswire 20 Dec 2024
CRENESSITY, a First-in-Class Treatment for Classic Congenital Adrenal Hyperplasia (CAH), is now commercially available in the U.S ... of age and older with classic congenital adrenal hyperplasia (CAH).

Most Viewed

×